These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 253513)

  • 1. [How hazardous are cytostatic agents to personnel?].
    Johansson H
    Vardfacket; 1979 Jan; 3(1):10-6. PubMed ID: 253513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safety for the handling of cytostatic substances. Protective measures are useful].
    Schmid B
    Krankenpfl Soins Infirm; 1985 Jul; 78(7):39-41, 66-8. PubMed ID: 3850203
    [No Abstract]   [Full Text] [Related]  

  • 3. Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications.
    Tortorici MP
    Hosp Pharm; 1980 Jun; 15(6):293, 295-6, 298-9 passim. PubMed ID: 10247268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational Safety and Health Administration.
    Yodaiken RE; Bennett D
    Am J Hosp Pharm; 1986 May; 43(5):1193-204. PubMed ID: 3717176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing guidelines for working with antineoplastic drugs.
    Harrison BR
    Am J Hosp Pharm; 1981 Nov; 38(11):1686-93. PubMed ID: 7304620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological manifestations in workers engaged in the production or administration of cytostatic drugs].
    Nava C; Briatico Vangosa G; Forni A
    Boll Chim Farm; 1984 Dec; 123(12):547-51. PubMed ID: 6398701
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy exposure file.
    Young RL; Du Vall EM
    Am J Hosp Pharm; 1985 Sep; 42(9):1990-1. PubMed ID: 3840330
    [No Abstract]   [Full Text] [Related]  

  • 8. Re-evaluation of urine mutagenicity of pharmacy personnel exposed to antineoplastic agents.
    Connor TH; Theiss JC; Anderson RW; Puckett WH; Matney TS
    Am J Hosp Pharm; 1986 May; 43(5):1236-9. PubMed ID: 3521267
    [No Abstract]   [Full Text] [Related]  

  • 9. Exposure to cytotoxic agents because of inadequate shipping containers.
    Katsumata EN; Blanchard MP; Kitajima DS
    Am J Hosp Pharm; 1986 Sep; 43(9):2143. PubMed ID: 3766561
    [No Abstract]   [Full Text] [Related]  

  • 10. Complying with workers' right-to-know legislation.
    Knoeck MJ; Wadd WB; Giese RM
    Am J Hosp Pharm; 1985 Sep; 42(9):1974-6. PubMed ID: 4050815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendation concerning protective measures. Safety for the handling of cytostatic substances. The current situation--a "Swiss compromise"].
    Senn HJ
    Krankenpfl Soins Infirm; 1985 Jul; 78(7):38-9, 65-6. PubMed ID: 3850202
    [No Abstract]   [Full Text] [Related]  

  • 12. [Centralized preparations of cytostatic agents: a method for quality control].
    Wernli M; Bögli F; Mühlebach S; Conen D
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1962-5. PubMed ID: 7973528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The handling of antineoplastic drugs in a major cancer center.
    Hoffman DM
    Hosp Pharm; 1980 Jun; 15(6):302-4. PubMed ID: 10247269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the safe handling of injectable antineoplastic drug products.
    Zimmerman PF; Larsen RK; Barkley EW; Gallelli JF
    Am J Hosp Pharm; 1981 Nov; 38(11):1693-5. PubMed ID: 7304621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legal issues associated with the handling of cytotoxic drugs.
    Provost GJ
    Am J Hosp Pharm; 1984 Jun; 41(6):1115-21. PubMed ID: 6234797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nurses' working environment. Elimination of cytostatic agents--focus on protection effort].
    Bråthen A; Rønning ME; Spilling J
    Sykepleien; 1986 Aug; 73(14):19-23, 42. PubMed ID: 3638820
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic chemotherapy: a potential hazard to patients and hospital personnel?
    Colls BM
    N Z Med J; 1987 Mar; 100(819):149-50. PubMed ID: 3452026
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible occupational hazards associated with the preparation/administration of antineoplastic agents.
    Crudi CB; Stephens BL; Maier P
    NITA; 1982; 5(4):264-5. PubMed ID: 6922411
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for handling cytotoxic drugs in hospitals.
    Stolar MH; Power LA; Viele CS
    Am J Hosp Pharm; 1983 Jul; 40(7):1163-71. PubMed ID: 6881154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.